Federal Register / Vol. 65, No. 223 / Friday, November 17, 2000 / Notices 69565

Background information on this issue is

available via the Internet at:

www.mchb.hrsa.gov.

In addition, this program is subject to

Title IX of the Education Amendments

of 1972 (20 U.S.C. §§ 1861–62), which

prohibits discrimination based on sex in

programs which receive Federal

financial assistance.

Eligibility

Under SPRANS project grant

regulations at 42 CFR Part 51a.3, any

public or private entity, including an

Indian tribe or tribal organization (as

defined at 25 U.S.C. 450(b)), is eligible

to apply for grants covered by this

announcement. Projects must clearly

and consistently focus on the designated

definition of ‘‘abstinence education’’

and applicants must agree not to

provide a participating adolescent any

other education regarding sexual

conduct in the same setting.

Applicants proposing to provide

abstinence-only education and who

have a public health mandate, such as

State or local health departments,

community health centers or other

community-based clinics, must provide

assurance that any discussion of other

forms of sexual conduct or provision of

services is conducted in a setting

different from where and when the

abstinence-only course is being

conducted.

Funding Level/Project Period

Two types of grants will be awarded

in FY 2001 under this program—oneyear planning grants, with awards

ranging from $50,000 to $75,000; and

three-year implementation grants, with

awards ranging from $250,000 to

$1,000,000 per year. Planning grant

funding will support program planning,

training and community assessment

activities. Implementation grant funding

will support the development and

implementation of three-year projects.

Approximately $1.5 million will be

awarded to support 15 to 20 planning

grants; about $15.5 million will be

awarded to support 25 to 50

implementation grants. Some

adjustment in funding amounts between

categories may be made, depending on

the number and quality of applications

received.

The project period consists of one or

more budget periods, each generally of

one year duration. Continuation of any

project from one budget period to the

next is subject to satisfactory

performance, availability of funds, and

program priorities.

Funding Priorities

Priority for funding will be given to

entities in local communities which

demonstrate a strong record of support

for abstinence education among

adolescents. An approved proposal that

reflects this priority will receive a 5-

point favorable adjustment in the

priority score, before funding decisions

are made.

Review Criteria

The following are generic review

criteria applicable to all MCHB

programs:

(1) The extent to which the project

will contribute to the advancement of

maternal and child health and/or

improvement of the health of children

with special health care needs;

(2) The extent to which the project is

responsive to policy concerns

applicable to MCH grants and to

program objectives, requirements,

priorities and/or review criteria for

specific project categories, as published

in program announcements or guidance

materials;

(3) The extent to which the estimated

cost to the Government of the project is

reasonable, considering the anticipated

results;

(4) The extent to which the project

personnel are well qualified by training

and/or experience for their roles in the

project and the applicant organization

has adequate facilities and personnel;

and

(5) The extent to which, insofar as

practicable, the proposed activities, if

well executed, are capable of attaining

project objectives.

The final review criteria used to

review and rank applications for the

SPRANS Community-Based Abstinence

Education grant program are included in

the application kit. Applicants should

pay strict attention to addressing these

criteria, as they are the basis upon

which their applications will be judged.

Public Health System Reporting

Requirements

This program is subject to the Public

Health System Reporting Requirements

(approved under OMB No. 0937–0195).

Under these requirements, the

community-based nongovernmental

applicant must prepare and submit a

Public Health System Impact Statement

(PHSIS). The PHSIS is intended to

provide information to State and local

health officials to keep them apprised of

proposed health services grant

applications submitted by communitybased nongovernmental organizations

within their jurisdictions.

Community-based nongovernmental

applicants are required to submit the

following information to the head of the

appropriate State and local health

agencies in the area(s) to be impacted no

later than the Federal application

receipt due date:

(a) A copy of the face page of the

application (SF 525).

(b) A summary of the project (PHSIS),

not to exceed one page, which provides:

(1) A description of the population to

be served.

(2) A summary of the services to be

provided.

(3) A description of the coordination

planned with the appropriate State and

local health agencies.

Executive Order 12372

The MCH Federal Set-Aside program

has been determined to be a program

which is not subject to the provisions of

Executive Order 12372 concerning

intergovernmental review of Federal

programs.

Dated: November 13, 2000.

Claude Earl Fox,

Administrator.

[FR Doc. 00–29425 Filed 11–16–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the meeting of the

Board of Scientific Counselors, National

Cancer Institute.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in sections

552b(c)(6) and 552b(c)(9)(B), Title 5

U.S.C., as amended. The discussions

could reveal information of a personal

nature where disclosure would

constitute a clearly unwarranted

invasion of personal privacy and the

premature disclosure of discussions

related to personnel and programmatic

issues would be likely to significantly

frustrate the subsequent implementation

of recommendations.

Name of Committee: Board of Scientific

Counselors, National Cancer Institute

Subcommittee A—Clinical Sciences and

Epidemiology.

Date: November 27–28, 2000.

Closed: November 27, 2000, 7:00 p.m. to

9:15 p.m.

Agenda: Discussion of personnel and

programmatic issues and review and evaluate

individual Principal Investigators.

69566 Federal Register / Vol. 65, No. 223 / Friday, November 17, 2000 / Notices

Place: Holiday Inn—Washington/Chevy

Chase, 5520 Wisconsin Avenue, Chevy

Chase, MD 20815.

Closed: November 28, 2000, 8:30 a.m. to

5:30 p.m.

Agenda: Discussion of personnel and

programmatic issues and review and evaluate

individual Principal Investigators.

Place: National Cancer Institute, Building

31, C Wing, 6th Floor, Conference Room 6,

9000 Rockville Pike, Bethesda, MD 20892.

Contact Person: Abby Sandler, Ph.D.,

Executive Secretary, Institute Review Office,

Office of the Director, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, Room 7019, Rockville,

MD 20852, (301) 496–7628.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support,

93.398, Cancer Research Manpower, 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: November 9, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–29430 Filed 11–16–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Cancer

Prevention Research Small Grant Program.

Date: December 5–6, 2000.

Time: 6 p.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ramada Inn, 1775 Rockville Pike,

Rockville, MD 20852.

Contact Person: Sherwood Githens, PhD.,

Scientific Review Administrator, National

Institutes of Health, National Cancer

Institute, Special Review, Referral and

Resources Branch, 6116 Executive Boulevard,

Room 8068, Bethesda, MD 20892, (301) 435–

1822.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: November 7, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–29435 Filed 11–16–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Child Health and Human Development

Special Emphasis Panel.

Date: November 16–17, 2000.

Time: 4:00 p.m. to 12:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Holiday Inn, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Jon M. Ranhand, PhD.,

Scientist Review Administrator, Division of

Scientific Review, National Institute of Child

Health and Human Development, NIH, 6100

Executive Blvd., Room 5E03, Bethesda, MD

20892, (301) 435–6884.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.209, Contraception and

Infertility Loan Repayment Program; 93.864,

Population Research; 93.865, Research for

Mothers and Children; 93,929, Center for

Medical Rehabilitation Research, National

Institutes of Health, HHS)

Dated: November 7, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–29427 Filed 11–16–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Neurological

Disorders and Stroke; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Neurological Disorders and Stroke Special

Emphasis Panel.

Date: December 13–14, 2000.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Melrose Hotel, 2430 Pennsylvania

Avenue, NW., Washington, DC 20037.

Contact Person: Richard D. Crosland, PhD.,

Scientific Review Administrator, Scientific

Review Branch, Division of Extramural

Research, NINDS/NIH/DHHS, Neuroscience

Center, 6001 Executive Blvd., Suite 3208,

MSC 9529, Bethesda, MD 20892–9529, 301–

594–0635.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.853, Clinical Research

Related to Neurological Disorders; 93.854,

Biological Basis Research in the

Neurosciences, National Institutes of Health,

HHS)

Dated: November 9, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–29429 Filed 11–16–00; 8:45 am]

BILLING CODE 4140–01–M